platincasinonodepositbonus| Xiansheng Pharmaceutical (02096): Spending HK$8.935 million to repurchase 1.565 million shares

News summary

Xiansheng Pharmaceutical (02096) adopts stock repurchase planplatincasinonodepositbonus, threw 893 on May 14platincasinonodepositbonus.50,000 Hong Kong dollars, successfully attracting 156platincasinonodepositbonus.50,000 shares.

Newsletter text

[Xiansheng Pharmaceutical (02096) spent nearly HK$9 million to implement share repurchase] On May 14, 2024, Xiansheng Pharmaceutical (02096) announced that it would spend HK$8.935 million to repurchase 1.565 million shares, highlightingplatincasinonodepositbonusThe company's confidence in its own value.

This repurchase may have a positive impact on secondary market investors and raise the market's expectations for the company's future development.

Through this repurchase, Xiansheng Pharmaceutical demonstrated its strong financial strength and confidence in the company's continued growth in the future.